WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2001085752) A NOVEL PEPTIDE-HUMAN MYOSIN HEAVY CHAIN 12-14 AND THE POLYNUCLEOTIDE CODING THIS NOVEL PEPTIDE
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2001/085752    International Application No.:    PCT/CN2001/000670
Publication Date: 15.11.2001 International Filing Date: 28.04.2001
IPC:
A61K 38/00 (2006.01), C07K 14/47 (2006.01)
Applicants: SHANGHAI BIOWINDOW GENE DEVELOPMENT INC. [CN/CN]; 3rd Building 12th Floor 1111 Zhongshan Bei Er Road Shanghai 200092 (CN) (For All Designated States Except US).
MAO, Yumin [CN/CN]; (CN) (For US Only).
XIE, Yi [CN/CN]; (CN) (For US Only)
Inventors: MAO, Yumin; (CN).
XIE, Yi; (CN)
Agent: SHANGHAI HUA DONG PATENT AGENCY; 319 Yue Yang Road Shanghai 200031 (CN)
Priority Data:
00 1 15544.X 29.04.2000 CN
Title (EN) A NOVEL PEPTIDE-HUMAN MYOSIN HEAVY CHAIN 12-14 AND THE POLYNUCLEOTIDE CODING THIS NOVEL PEPTIDE
(FR) POLYNUCLEOTIDE CODANT UN PEPTIDE DE MYOSINE
Abstract: front page image
(EN)This invention discloses a novel peptide-Human myosin heavy chain 12-14, polynucleotide coding this peptide and the method producing this peptide by DNA recombination techniques. This invention also discloses the therapeutical methods with this peptide for several diseases, such as PWS, AS, Klinefelter syndrome and some kinetic illness, inflammations, et al. This invention also discloses and antagonist against this peptide and its therapeutical effect. The invention also discloses the use of this polynucleotide coding the novel human myosin heavy chain 12-14.
(FR)L'invention concerne un peptide, la chaîne lourde 12-14 de la myosine humaine, le polynucléotide codant pour ce peptide ainsi que le procédé de production de ce peptide par des techniques de recombinaison de l'ADN. Elle concerne aussi les méthodes thérapeutiques utilisant ce peptide pour plusieurs maladies telles que syndromes de Prader-Willi, syndrome d'Angelman, syndrome de Klinefelter, certaines maladies cinétiques, maladies inflammatoires et autres. Elle concerne encore un antagoniste de ce peptide et son effet thérapeutique. Elle concerne enfin l'utilisation du polynucléotide codant pour la chaîne 12-14 de la myosine humaine.
Designated States: AE, AG, AL, AM, AT, AU, AZ, BA, BB, BG, BR, BY, BZ, CA, CH, CO, CR, CU, CZ, DE, DK, DM, DZ, EE, ES, FI, GB, GD, GE, GH, GM, HR, HU, ID, IL, IN, IS, JP, KE, KG, KP, KR, KZ, LC, LK, LR, LS, LT, LU, LV, MA, MD, MG, MK, MN, MW, MX, MZ, NO, NZ, PL, PT, RO, RU, SD, SE, SG, SI, SK, SL, TJ, TM, TR, TT, TZ, UA, UG, US, UZ, VN, YU, ZA, ZW.
African Regional Intellectual Property Organization (GH, GM, KE, LS, MW, MZ, SD, SL, SZ, TZ, UG, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, CH, CY, DE, DK, ES, FI, FR, GB, GR, IE, IT, LU, MC, NL, PT, SE, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GW, ML, MR, NE, SN, TD, TG).
Publication Language: Chinese (ZH)
Filing Language: Chinese (ZH)